Skip to Main Content
Skip Nav Destination

Red Book Online Outbreaks: Listeria Outbreak Linked to Queso Fresco and Cotija Cheese

February 21, 2024


CDC is currently investigating a multistate Listeria monocytogenes outbreak linked to queso fresco and cotija cheese. As of February 13, 2024, there have been 26 illnesses, including 23 hospitalizations and 2 deaths.

On February 6, 2024, Rizo-Lopez Foods, Inc. recalled all cheese and other dairy products made in their facility.  They have temporarily stopped producing and distributing these products while their investigation is ongoing. A list of recalled products, brands, sizes, UPC and sell-by dates can be found in the firm’s press release.

Clinical Guidance


  • Listeria usually causes common food poisoning signs and symptoms, like fever and diarrhea. People who experience these symptoms usually recover without treatment. Symptoms of self-limited febrile gastroenteritis usually start within 24 hours of ingesting contaminated food and last 2-3 days.
  • Less commonly, Listeria can cause severe illness (known as invasive listeriosis) when the bacteria spread beyond the gut to other parts of the body. Symptoms of invasive listeriosis usually start 1 to 4 weeks after eating contaminated food but may occasionally start even later.
    • Pregnant people with invasive listeriosis usually experience only fever, fatigue, muscle aches, and occasionally gastrointestinal tract infections.
    • Non-pregnant people with invasive listeriosis may experience headaches, stiff neck, confusion, loss of balance, and convulsions, in addition to fever and muscle aches.
  • Patients should be seen by their pediatrician right away if they exhibit any signs or symptoms of Listeria infection after eating the cheese.

Who is at the highest risk/complications?

  • People who are 65 years or older, are pregnant, or are immunocompromised.
  • Listeria can cause pregnancy loss or premature birth.
  • Listeria can also cause serious illness or death in newborns.


  • L monocytogenes can be recovered readily on blood agar from cultures of blood, cerebrospinal fluid (CSF), meconium, placental or fetal tissue specimens, amniotic fluid, and other infected tissue specimens, including joint, pleural, or peritoneal fluid. 
  • Polymerase chain reaction (PCR) assays can be used to detect L monocytogenes in blood and CSF. 
  • Stool cultures are generally not useful for the diagnosis of Listeria infection.


  • People should not eat any recalled cheeses or dairy products.
    • People should check their refrigerators and freezers. Listeria can survive in the refrigerator and easily spread to other foods and surfaces. People should clean any surfaces or containers that may have touched the recalled cheese. Listeria can survive at freezing temperatures.
    • Recalled food should be thrown away or returned to where they were purchased for a refund.

Risk Mitigation:

  • Antimicrobial therapy for infection diagnosed during pregnancy may prevent fetal or perinatal infection and its consequences.


  • Combination therapy using ampicillin and a second agent in doses appropriate for meningitis is recommended for severe infections. An aminoglycoside, typically gentamicin, usually is used as the second agent in combination therapy. Use of an alternative second agent that is active intracellularly (eg, trimethoprim-sulfamethoxazole [contraindicated in infants younger than 2 months], fluoroquinolones, linezolid, or rifampin) is supported by case reports in adults. If alternatives to gentamicin are used, susceptibility should be confirmed because resistance to trimethoprim-sulfamethoxazole, fluoroquinolones, linezolid, or rifampin occasionally has been reported. In the penicillin-allergic patient, options include either penicillin desensitization or use of either trimethoprim-sulfamethoxazole or a fluoroquinolone, both of which have been used successfully as monotherapy for Listeria meningitis and in the setting of brain abscess. Treatment failures with vancomycin have been reported. Cephalosporins are not active against L  monocytogenes.
  • For bacteremia without associated central nervous system infection, 14 days of treatment is recommended. For L monocytogenes meningitis, most experts recommend 3 to 4 weeks of treatment. Longer courses are necessary for patients with endocarditis or parenchymal brain infection (cerebritis, rhombencephalitis, brain abscess). Iron may enhance the pathogenicity of L monocytogenes; iron supplements should be withheld until treatment for listeriosis is complete. Diagnostic imaging of the brain near the end of the anticipated duration of therapy allows determination of parenchymal involvement of the brain and the need for prolonged therapy in neonates with complicated courses and in immunocompromised patients.


  • Listeriosis is a nationally notifiable disease in the United States.
  • Cases should be reported promptly to the state or local health department to facilitate early recognition and control of common-source outbreaks.
  • Clinical isolates should be forwarded to a public health laboratory for genetic sequencing.


Pediatric Practice Tools and Information

Listeria (Listeriosis) | CDC


Public Health Resources

Food Safety Alert | Listeria Outbreak Linked to Queso Fresco and Cotija Cheese | CDC

Outbreak Investigation: Queso Fresco and Cotija Cheese | FDA


Infection Prevention and Control Resources

Project Firstline (


Information for Patients and Caregivers

AAP Listeriosis in Infants, Children & Pregnant People | In Spanish: Infección por listeriosis en bebés, niños y embarazadas

Close Modal

or Create an Account

Close Modal
Close Modal